Less dementia and stroke in low-risk patients with atrial fibrillation taking oral anticoagulation.

Back

ESC Premium Access

Less dementia and stroke in low-risk patients with atrial fibrillation taking oral anticoagulation.

Session: Adverse outcomes in atrial fibrillation: can they be prevented?

Topic: Epidemiology, Prognosis, Outcome

Speaker: Associate Professor L. Friberg (Stockholm, SE)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Associate Professor Leif Friberg

Friberg Research, Stockholm (Sweden)

1 presentation

0 follower

4 more presentations in this session

State of the Art - Prediction of stroke and dementia in atrial fibrillation

Speaker: Professor P. Kirchhof (Hamburg, DE)

Access

Slides

Video

Effect of hypertension duration and systolic blood pressure on dementia in patients with atrial fibrillation

Speaker: Doctor D. Kim (Seoul, KR)

Glucose is associated with future atrial fibrillation and heart failure already at prediabetes levels, a 19 year follow up of 243,665 subjects

Speaker: Doctor V. Lind (Stockholm, SE)

Predictors of thromboembolism in patients with atrial fibrillation and valvular heart disease according to the EHRA classification: beyond mitral stenosis and mechanical prosthetic heart valves

Speaker: Miss L. Melgaard (Aalborg, DK)

Access the full session

Adverse outcomes in atrial fibrillation: can they be prevented?

Speakers: Associate Professor L. Friberg, Professor P. Kirchhof, Doctor D. Kim, Doctor V. Lind, Miss L. Melgaard

Access

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources